Cargando…

Increased prevalence of left ventricular hypertrophy in hypertensive women with type 2 diabetes mellitus

BACKGROUND: Left ventricular hypertrophy (LVH) is a powerful independent risk factor for cardiovascular morbidity and mortality among hypertensive patients. Data regarding relationships between diabetes and LVH are controversial and inconclusive, whereas possible gender differences were not specific...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tenenbaum, Alexander, Fisman, Enrique Z, Schwammenthal, Ehud, Adler, Yehuda, Benderly, Michal, Motro, Michael, Shemesh, Joseph
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2003
Materias:	Original Investigation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC317343/ https://www.ncbi.nlm.nih.gov/pubmed/14633284 http://dx.doi.org/10.1186/1475-2840-2-14

Ejemplares similares

Does the lipid-lowering peroxisome proliferator-activated receptors ligand bezafibrate prevent colon cancer in patients with coronary artery disease?
por: Tenenbaum, Alexander, et al.
Publicado: (2008)

Long-term effects of peroxisome proliferator-activated receptor ligand bezafibrate on N-terminal pro-B type natriuretic peptide in patients with advanced functional capacity impairment
por: Node, Koichi, et al.
Publicado: (2009)

Atherogenic dyslipidemia in metabolic syndrome and type 2 diabetes: therapeutic options beyond statins
por: Tenenbaum, Alexander, et al.
Publicado: (2006)

Coronary calcium in patients with and without diabetes: first manifestation of acute or chronic coronary events is characterized by different calcification patterns
por: Shemesh, Joseph, et al.
Publicado: (2013)

Metabolic syndrome and type 2 diabetes mellitus: focus on peroxisome proliferator activated receptors (PPAR)
por: Tenenbaum, Alexander, et al.
Publicado: (2003)

Impact of type 2 diabetes mellitus on short- and long-term mortality after coronary artery bypass surgery
por: Kogan, Alexander, et al.
Publicado: (2018)

Type 2 diabetes mellitus increases long-term mortality risk after isolated surgical aortic valve replacement
por: Ram, Eilon, et al.
Publicado: (2019)

Screening for left ventricular hypertrophy in patients with type 2 diabetes mellitus in the community
por: Somaratne, Jithendra B, et al.
Publicado: (2011)

Cardiovascular diabetology in the core of a novel interleukins classification: the bad, the good and the aloof
por: Fisman, Enrique Z, et al.
Publicado: (2003)

Statins research unfinished saga: desirability versus feasibility
por: Fisman, Enrique Z, et al.
Publicado: (2005)

Dual and pan-peroxisome proliferator-activated receptors (PPAR) co-agonism: the bezafibrate lessons
por: Tenenbaum, Alexander, et al.
Publicado: (2005)

Losartan and diabetic nephropathy: commentaries on the RENAAL study
por: Fisman, Enrique Z, et al.
Publicado: (2002)

Type 2 diabetes mellitus increases the mortality risk after acute coronary syndrome treated with coronary artery bypass surgery
por: Ram, Eilon, et al.
Publicado: (2020)

Impaired fasting glucose and left ventricular diastolic dysfunction in middle-age adults: a retrospective cross-sectional analysis of 2971 subjects
por: Milwidsky, Assi, et al.
Publicado: (2015)

Revascularization outcomes in diabetic patients presenting with acute coronary syndrome with non-ST elevation
por: Ram, Eilon, et al.
Publicado: (2022)

Hypomagnesemia is associated with new-onset diabetes mellitus following heart transplantation
por: Peled, Yael, et al.
Publicado: (2019)

Hyperglycemia and nocturnal systolic blood pressure are associatedwith left ventricular hypertrophy and diastolic dysfunction in hypertensive diabetic patients
por: Felício, João S, et al.
Publicado: (2006)

Renal glucosuria is associated with lower body weight and lower rates of elevated systolic blood pressure: results of a nationwide cross-sectional study of 2.5 million adolescents
por: Fishman, Boris, et al.
Publicado: (2019)

Optimized electrocardiographic criteria for the detection of left ventricular hypertrophy in obesity patients
por: Snelder, Sanne M., et al.
Publicado: (2020)

Admission blood glucose and 10-year mortality among patients with or without pre-existing diabetes mellitus hospitalized with heart failure
por: Itzhaki Ben Zadok, Osnat, et al.
Publicado: (2017)

High-Throughput Precision Phenotyping of Left Ventricular Hypertrophy With Cardiovascular Deep Learning
por: Duffy, Grant, et al.
Publicado: (2022)

Metformin therapy in patients with diabetes mellitus is associated with a reduced risk of vasculopathy and cardiovascular mortality after heart transplantation
por: Ram, Eilon, et al.
Publicado: (2019)

Left Ventricular Mass Formulae and Prevalence Rates of Echocardiographic Left Ventricular Hypertrophy in Nigerians with Essential Hypertension
por: Adekunle, Ajayi Ebenezer, et al.
Publicado: (2013)

Echocardiographic partition values and prevalence of left ventricular hypertrophy in hypertensive Nigerians
por: Adebiyi, Adewole A, et al.
Publicado: (2006)

Association of Nighttime Masked Uncontrolled Hypertension With Left Ventricular Hypertrophy and Kidney Function Among Patients with Chronic Kidney Disease Not Receiving Dialysis
por: Fu, Xiaocen, et al.
Publicado: (2022)

Deficiency of Tregs in hypertension‐associated left ventricular hypertrophy
por: Tang, Ying, et al.
Publicado: (2023)

Association of Left Atrial Volume With Mortality Among ESRD Patients With Left Ventricular Hypertrophy Referred for Kidney Transplantation
por: Patel, Rajan K., et al.
Publicado: (2010)

Prevalence and Characterisation of Severe Left Ventricular Hypertrophy Diagnosed by Echocardiography in Hypertensive Patients
por: Apitz, Anett, et al.
Publicado: (2022)

The effect of raloxifene on left ventricular hypertrophy in postmenopausal women: A prospective, randomized, and controlled study
por: Bal, Uğur Abbas, et al.
Publicado: (2015)

Associations of Biomarkers of Kidney Tubule Health, Injury, and Inflammation with Left Ventricular Hypertrophy in Children with CKD
por: Jiang, Kuan, et al.
Publicado: (2023)

Hypertension and hyperparathyroidism are associated with left ventricular hypertrophy in patients on hemodialysis
por: Al-Hilali, N., et al.
Publicado: (2009)

Left Ventricular Hypertrophy in Pediatric Hypertension: A Mini Review
por: Woroniecki, Robert P., et al.
Publicado: (2017)

Combined superposition effect of hypertension and dyslipidemia on left ventricular hypertrophy
por: Zhang, Xueyao, et al.
Publicado: (2022)

Left ventricular hypertrophy in hypertension: Is the electrocardiogram enough for risk stratification?
por: Cuspidi, Cesare, et al.
Publicado: (2022)

Left ventricular hypertrophy in hypertension: Need of ethnic‐specific criteria
por: Cuspidi, Cesare, et al.
Publicado: (2022)

Is hypertensive left ventricular hypertrophy a cause of sustained ventricular arrhythmias in humans?
por: Nadarajah, R., et al.
Publicado: (2021)

Ratio of Fabry disease in patients with idiopathic left ventricular hypertrophy: A single-center study in Turkey
por: Barman, Hasan Ali, et al.
Publicado: (2020)

Prevalence of left ventricular hypertrophy in children and young people with primary hypertension: Meta-analysis and meta-regression
por: Sinha, Manish D., et al.
Publicado: (2022)

Intramural Reentrant Ventricular Tachycardia in a Patient with Severe Hypertensive Left Ventricular Hypertrophy
por: Lin, Chin-Yu, et al.
Publicado: (2015)

Relationship Between Circulating MicroRNAs and Left Ventricular Hypertrophy in Hypertensive Patients
por: Lopes, Elisangela C. P., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_o4no1jffnc2bq2a757ldbtkfg9